| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2220 | 2018 |
| Intensity of continuous renal-replacement therapy in critically ill patients RENAL Replacement Therapy Study Investigators New England Journal of Medicine 361 (17), 1627-1638, 2009 | 1685 | 2009 |
| Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study GV Long, V Atkinson, S Lo, S Sandhu, AD Guminski, MP Brown, ... The Lancet Oncology 19 (5), 672-681, 2018 | 903 | 2018 |
| A randomized, controlled trial of oral propranolol in infantile hemangioma C Léauté-Labrèze, P Hoeger, J Mazereeuw-Hautier, L Guibaud, ... New England Journal of Medicine 372 (8), 735-746, 2015 | 834 | 2015 |
| Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy TN Gide, C Quek, AM Menzies, AT Tasker, P Shang, J Holst, J Madore, ... Cancer cell 35 (2), 238-255. e6, 2019 | 662 | 2019 |
| Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer J Tie, JD Cohen, K Lahouel, SN Lo, Y Wang, S Kosmider, R Wong, ... New England Journal of Medicine 386 (24), 2261-2272, 2022 | 482 | 2022 |
| Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis AG Schneider, R Bellomo, SM Bagshaw, NJ Glassford, S Lo, M Jun, ... Intensive care medicine 39, 987-997, 2013 | 368 | 2013 |
| Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC) AM Menzies, RN Amaria, EA Rozeman, AC Huang, MT Tetzlaff, ... Nature medicine 27 (2), 301-309, 2021 | 326 | 2021 |
| Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma JH Lee, GV Long, S Boyd, S Lo, AM Menzies, V Tembe, A Guminski, ... Annals of Oncology 28 (5), 1130-1136, 2017 | 315 | 2017 |
| An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial RENAL Replacement Therapy Study Investigators Critical care medicine 40 (6), 1753-1760, 2012 | 315 | 2012 |
| Association between circulating tumor DNA and pseudoprogression in patients with metastatic melanoma treated with anti–programmed cell death 1 antibodies JH Lee, GV Long, AM Menzies, S Lo, A Guminski, K Whitbourne, ... JAMA oncology 4 (5), 717-721, 2018 | 285 | 2018 |
| Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets F Newell, Y Kong, JS Wilmott, PA Johansson, PM Ferguson, C Cui, Z Li, ... Nature communications 10 (1), 3163, 2019 | 246 | 2019 |
| Dynamic changes in PD-L1 expression and immune infiltrates early during treatment predict response to PD-1 blockade in melanoma RE Vilain, AM Menzies, JS Wilmott, H Kakavand, J Madore, A Guminski, ... Clinical Cancer Research 23 (17), 5024-5033, 2017 | 246 | 2017 |
| Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement … DJ Gattas, A Dan, J Myburgh, L Billot, S Lo, S Finfer, ... Intensive care medicine 39, 558-568, 2013 | 208 | 2013 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 202 | 2019 |
| A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults DJ Gattas, D Rajbhandari, C Bradford, H Buhr, S Lo, R Bellomo Critical care medicine 43 (8), 1622-1629, 2015 | 181 | 2015 |
| Effect of intensive patient education vs placebo patient education on outcomes in patients with acute low back pain: a randomized clinical trial AC Traeger, H Lee, M Hübscher, IW Skinner, GL Moseley, MK Nicholas, ... JAMA neurology 76 (2), 161-169, 2019 | 166 | 2019 |
| The bidirectional relationship between pain intensity and sleep disturbance/quality in patients with low back pain SM Alsaadi, JH McAuley, JM Hush, S Lo, DJ Bartlett, RR Grunstein, ... The Clinical journal of pain 30 (9), 755-765, 2014 | 162 | 2014 |
| Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial GV Long, RPM Saw, S Lo, OE Nieweg, KF Shannon, M Gonzalez, ... The Lancet Oncology 20 (7), 961-971, 2019 | 157 | 2019 |
| Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma E Liniker, AM Menzies, BY Kong, A Cooper, S Ramanujam, S Lo, ... Oncoimmunology 5 (9), e1214788, 2016 | 154 | 2016 |
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred Hospital在 sswahs.nsw.gov.au 的电子邮件经过验证
